Delivery Order SPE2DB22D1106-SPE2DB25FEGD7

Award Date 4/3/25
Potential Completion Date 4/4/25
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of DALVANCE 500 MG VIALS to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $3,585.12, has a completion date of May 15, 2025. The contract is not set aside and allows for the supply of a range of pharmaceutical products and medical supplies to support military healthcare programs. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award, SPE2DB22D3501|SPE2DB24FWJ02, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,759.66, is for the delivery of 4565215249 DALVANCE 500 MG VIALS. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
This federal contract award, valued at $6,474.29, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DALVANCE 500 MG VIALS, a pharmaceutical product, with a completion date of February 19, 2025. The contract is a Delivery Order, with a Firm Fixed Price pricing type. It is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a significant...
This federal contract award is for the delivery of DALVANCE 500 MG VIALS to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $2,688.84 and has an ultimate completion date of January 13, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,535.20, is for the delivery of DALVANCE 500 MG VIALS, a pharmaceutical product. The contract is a delivery order with a firm fixed price pricing type, and the ultimate completion date is January 4, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) held by...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of DALVANCE 500 MG VIALS. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, with a ceiling value of $3,183.01. It is a delivery order contract with a firm fixed price pricing type. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,511.57 Firm Fixed Price Delivery Order contract is for the supply of 4566973168 DALVANCE 500 MG VIALS. The contract has an ultimate completion date of January 21, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,197.98, is for the procurement of DALVANCE 500 MG VIALS. It is a Firm Fixed Price Delivery Order contract with a completion date of May 14, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award, with ID SPE2DB22D6029|SPE2DB25FLTTP, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,792.56 firm fixed-price delivery order is for the supply of 4566987527 DALVANCE 500 MG VIALS. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DALVANCE 500 MG VIALS, a pharmaceutical product, with a ceiling value of $5,771.79. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FEGD7
    Delivery Order

This federal contract award, with an ID of SPE2DB22D1106|SPE2DB25FEGD7, was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp. The contract is for the delivery of DALVANCE 500 MG VIALS, a pharmaceutical product, with a ceiling value of $12,073.61 and a period of performance through April 4, 2025.

Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific contract award is not designated with a set-aside requirement, indicating open competition.

Generated 7/3/25, 3:05 PM